Superior outcomes in HIV-positive kidney transplant patients compared with HCV-infected or HIV/HCV-coinfected recipients

Kidney International

Volumn 88, Issue 2, 2015, Pages 341-349

  Sawinski, Deirdre ^a   Forde, Kimberly A ^a,b   Eddinger, Kevin ^b   Troxel, Andrea B ^b   Blumberg, Emily ^c   Tebas, Pablo ^c   Abt, Peter L ^c   Bloom, Roy D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Hepatitis C (HCV); human immunodeficiency virus (HIV); kidney transplant; outcomes

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; COINFECTION; COMPARATIVE STUDY; COMPLICATION; GRAFT REJECTION; HIV SEROPOSITIVITY; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; UNITED STATES; VIROLOGY;

ADULT; COINFECTION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS C; HIV SEROPOSITIVITY; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES;

EID: 84938531019     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2015.74     Document Type: Article

References (24)

1. Swanson SJ, Kirk AD, Ko CW et al. Impact of HIV seropositivity on graft and patient survival after cadaveric renal transplantation in the United States in the pre highly active antiretroviral therapy (HAART) era: an historical cohort analysis of the United States Renal Data System. Transpl Infect Dis 2002; 4: 144-147
2. Stock PG, Barin B, Murphy B et al. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med 2010; 363: 2004-2014
3. Landin L, Rodriguez-Perez JC, Garcia-Bello MA et al. Kidney transplants in HIV-positive recipients under HAART. A comprehensive review and meta-analysis of 12 series. Nephrol Dial Transplant 2010; 25: 3106-3115
4. Mazuecos A, Fernandez A, Andres A et al. HIV infection and renal transplantation. Nephrol Dial Transplant 2011; 26: 1401-1407
5. Touzot M, Pillebout E, Matignon M et al. Renal transplantation in HIV-infected patients: the Paris experience. Am J Transplant 2010; 10: 2263-2269
6. Trullas JC, Cofan F, Barril G et al. Spanish HIV Infection in Dialysis Study Group. Outcome and prognostic factors in HIV-1 infected patients on dialysis in the cART era: a GESIDA/SEN cohort study. J Acquir Immune Defic Syndr 2011; 57: 276-283
7. Kumar MS, Khan SM, Ranganna K et al. In HIV+ patients with end stage renal disease (ESRD) kidney transplantation significantly prolongs long-Term patient survival compared to chronic dialysis treatment. Abstract presented at American Transplant Congress. Toronto, Canada, 2008
8. Fissell RB, Bragg-Gresham JL, Woods JD et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 2004; 65: 2335-2342
9. Kidney Disease: Improving Global Outcomes. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of Hepatitis C in chronic kidney disease. Kidney Int 2008; 73(Suppl 109): S1-S99
10. Bloom RD, Sayer G, Fa K et al. Outcome of Hepatitis C virus Infected Kidney Transplant Candidates who Remain on the Waiting List. Am J Transplant 2005; 5: 139-144
11. Ingsathit A, Kamanamool N, Thakkinstian A et al. Survival advantage of kidney transplantation over dialysis in patients with hepatitis C: a systematic review and meta-analysis. Transplantation 2013; 95: 943-948
12. Fabrizi F, Martin P, Dixit V et al. Hepatitis C virus antibody status and survival after renal transplantation: meta analysis of observational studies. Am J Transplant 2005; 5: 1452-1461
13. Batty DS, Swanson SJ, Kirk AD et al. Hepatitis C seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant 2001; 1: 179-184
14. Fabrizi F, Dulai G, Dixit V et al. Meta analysis: interferon for the treatment of chronic hepatitis C in dialysis patients. Aliment Pharmacol Ther 2003; 18: 1071-1081
15. Russo MW, Goldsweig CD, Jacobsen IM et al. Interferon monotherapy for dialysis patient with chronic hepatitis C: an analysis of the literature on efficacy and safety. Am J Gastroenterol 2003; 98: 1610-1615
16. Ozgur O, Boyacioglu S, Telatar H et al. Recombinant alpha interferon in renal allograft recipients with chronic hepatitis C. Nephrol Dial Transplant 1995; 10: 2104-2106
17. Rostaing l, Izopet J, Baron E et al. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation 1995; 59: 1426-1431
18. Abbott KC, Bucci JR, Matsumoto CS et al. Hepatitis C and Renal Transplantation in the Era of Modern Immunosuppression. J Am Soc Nephrol 2003; 14: 2908-2918
19. Xia Y, Friedmann P, Yaffe H et al. Effect of HCV, HIV and coinfection in kidney transplant recipients: mate kidney analyses. Am J Transplant 2014; 14: 2037-2047
20. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958; 53: 457-481
21. Cox D. Regression models and life tables. J R Stat Soc Ser 1972; 34: 187-220
22. Rothman KJ, Greenland S. Modern Epidemiology. 2nd edn. Lippincott Williams and Wilkins: Philadelphia, PA, 1998
23. Thereau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model (Statistics for Biology and Health). Springer: New York, USA, 2001
24. HIV Surveillance Report: Diagnoses of HIV Infection and AIDS in the United States and Dependent Areas, 2011; Vol. 23. Available at: http: //www.cdc.gov/hiv/statistics/basics (last accessed on 11 October 2014